False positive and false negative thyroid ^99mTc-sestamibi scintigraphy in the same patient

• References

• 1 Dietlein M, Wegscheider K, Vaupel R. et al. Survey of management of solitary thyroid nodules in Germany. Nuklearmedizin 2008; 47: 87-96.
• 2 Hurtado-Lopez LM, Martinez-Duncker C. Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules. Eur J Nucl Med Mol Imaging 2007; 34: 1701-1703.
• 3 Chamnanrabiabkij E, Welch A, Jayapaul MK, Perros P. Detection of Hürthle cell carcinoma using sesta- mibi. Thyroid 2008; 18: 575-576.
• 4 Mezosi E, Bajnok L, Gyory F. et al. The role of tech- netium-99m methoxyisobutylisonitrile scinti- graphy in the differential diagnosis of cold thyroid nodules. Eur J Nucl Med 1999; 26: 798-803.
• 5 Kresnik E, Gallowitsch HJ, Mikosch P. et al. Tech- netium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area. J Nucl Med 1997; 38: 62-65.
• 6 Sundram FX, Mack P. Evaluation of thyroid nodules for malignancy using ^99mTc-sestamibi. Nucl Med Commun 1995; 16: 687-693.
• 7 Theissen P, Schmidt M, Ivanova T. et al. MIBI scintigraphy in hypofunctioning thyroid nodules--can it predict the dignity of the lesion?. Nuklearmedizin 2009; 48: 144-152.
• 8 Boi F, Lai ML, Deias C. et al. The usefulness of ^99mTc- SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol 2003; 149: 493-498.
• 9 Vattimo A, Bertelli P, Cintorino M. et al. Identification of Hürthle cell tumor by single-injection, double-phase scintigraphy with technetium- 99m-sestamibi. J Nucl Med 1995; 36: 778-782.
• 10 Saggiorato E, Angusti T, Rosas R. et al. ^99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med 2009; 50: 1785-1793.